Benign neoplasm: Rectosigmoid junction

CD2_BENIGN_RECTOSIGMOID_JUNC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D12.7&
  • Cause of death: ICD-10 D12.7&

2 out of 7 registries used, show all original rules.

1409

4. Check minimum number of events

None

1409

5. Include endpoints

None

1409

6. Filter based on genotype QC (FinnGen only)

1409

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D12
Name in latin
Neoplasma benignum junctionis rectosigmoideae

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7788 3752 4004
Only index persons 7330 3571 3759
Unadjusted period prevalence (%)
Whole population 0.11 0.11 0.11
Only index persons 0.14 0.13 0.14
Median age at first event (years)
Whole population 67.02 67.20 66.82
Only index persons 66.65 66.81 66.51

-FinnGen-

Key figures

All Female Male
Number of individuals 1409 681 728
Unadjusted period prevalence (%) 0.28 0.23 0.32
Median age at first event (years) 66.16 65.34 66.92

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1239
Matched controls
12392
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
4503599627370496.0
323.0
1238
*
UJF32
NOMESCO Finland
Coloscopy
10.8
312.5
893
2383
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
14.7
211.5
382
365
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
8.5
147.2
358
562
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
12.0
133.5
259
266
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
11.1
113.3
228
247
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
4.2
95.9
459
1521
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
6.7
79.7
220
386
UJF30
NOMESCO Finland
Ileoscopy through colon
5.2
77.0
270
634
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
8.9
58.9
131
163
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
58.2
539
2688
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
11.5
57.3
110
104
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
11.2
43.0
83
79
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
8.1
42.9
100
133
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
7.1
35.5
90
136
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
33.2
489
2864
A02BC02
ATC
pantoprazole; systemic
1.9
24.1
857
6706
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
21.3
361
2151
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
21.2
386
2361
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
16.1
20.6
33
21
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
9.0
20.4
43
49
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
20.4
181
808
D12.9
ICD-10 Finland
Benign neoplasm: Anus and anal canal
10.8
20.0
38
36
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
19.6
131
497
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.7
19.6
141
560
JN4BD
NOMESCO Finland
Extensive body CT
2.3
19.0
191
906
K63.5
ICD-10 Finland
Polyp of colon
7.1
18.0
44
64
P01AB01
ATC
metronidazole; oral, rectal
1.7
17.6
484
3348
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
4.4
16.9
62
147
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
5.8
16.7
47
83
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.8
16.5
108
402
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.5
16.4
132
558
D06
ICPC
Abdominal pain localized other
2.7
16.4
120
481
WX002
NOMESCO Finland
Sedation and analgesia
1.9
16.2
296
1785
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
3.1
15.9
90
305
K92.1
ICD-10 Finland
Melaena
2.9
15.6
95
340
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
15.5
164
793
N02BE01
ATC
paracetamol; systemic, rectal
1.9
15.4
1057
9343
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
15.3
593
4461
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
15.0
167
824
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
11.5
14.8
27
24
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
13.8
286
1787
R4110
NOMESCO Finland
Physiotherapy
1.7
13.7
346
2294
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
13.6
225
1298
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.6
13.1
99
403
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
7.0
12.4
30
44
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.6
12.0
87
347
UJH02
NOMESCO Finland
Anoscopy
2.9
11.9
73
263
S18
ICPC
Laceration/cut
1.5
11.8
534
4079
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
11.7
203
1190
N02AX02
ATC
tramadol; systemic, rectal
1.5
11.5
521
3974
R06.0
ICD-10 Finland
Dyspnoea
1.6
11.5
325
2209
K62.1
ICD-10 Finland
Rectal polyp
6.6
11.3
28
43
JF2BD
NOMESCO Finland
Extensive colon CT
5.5
11.2
32
59
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.6
11.1
84
342
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
11.1
268
1737
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.2
11.0
58
190
D01
ICPC
Abdominal pain/cramps general
2.1
11.0
124
617
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
10.9
353
2476
R03AC02
ATC
salbutamol; inhalant
1.5
10.9
582
4586
J01CA04
ATC
amoxicillin; systemic
1.5
10.5
898
7815
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
5.3
10.5
31
60
R02
ICPC
Shortness of breath/dyspnoea
1.9
10.3
167
953
J01DA01
ATC
[U] cefalexin; systemic
1.5
10.2
718
5970
N03AX16
ATC
pregabalin; oral
1.6
9.8
289
1973
J01DB01
ATC
cefalexin; oral
1.5
9.7
954
8469
XF402
NOMESCO Finland
ECG with work load test
1.8
9.6
172
1013
A02BC05
ATC
esomeprazole; systemic
1.5
9.5
474
3652
L05
ICPC
Flank/axilla symptom/complaint
2.4
9.4
79
341
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
4.7
9.2
30
65
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.6
9.1
40
115
J01AA02
ATC
doxycycline; systemic
1.5
9.1
919
8133
B01AB05
ATC
enoxaparin; parenteral
1.5
9.0
398
2974
M54.5
ICD-10 Finland
Low back pain
1.5
9.0
353
2569
JFB46
NOMESCO Finland
Resection of sigmoid colon
4.9
9.0
28
58
UJG02
NOMESCO Finland
Proctoscopy
3.4
8.7
40
119
J01MA12
ATC
levofloxacin; systemic
1.6
8.7
240
1604
R53
ICD-10 Finland
Malaise and fatigue
1.6
8.6
241
1619
WX704
NOMESCO Finland
Intubation
2.2
8.5
89
429
JFA85
NOMESCO Finland
Endoscopic mucosal or submucosal resection in colon
27.7
8.5
11
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
8.4
237
1592
B82
ICPC
Anaemia other/unspecified
3.2
8.2
41
131
UJF34
NOMESCO Finland
Left colonoscopy
6.5
8.2
20
31
SPAT1263
SPAT
Sampling
1.4
8.2
488
3862
C07AB07
ATC
bisoprolol; oral
1.4
8.1
612
5055
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
8.1
530
4263
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
3.2
8.1
40
127
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
8.1
256
1771
D18
ICPC
Change in faeces/bowel movements
3.4
8.1
37
111
K59.1
ICD-10 Finland
Functional diarrhoea
2.3
7.9
68
301
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
8.5
7.8
16
19
WX110
NOMESCO Finland
Local anesthesy
1.4
7.8
740
6356
K85
ICPC
Elevated blood pressure
1.6
7.8
199
1301
WX290
NOMESCO Finland
Other blockade of nerve
1.4
7.7
406
3129
J01MA02
ATC
ciprofloxacin; systemic
1.4
7.7
464
3669
XF404
NOMESCO Finland
Ambulatory ECG
1.8
7.7
128
737
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
4.0
7.7
29
74
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
3.8
7.7
31
84
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.5
7.6
57
235
T90
ICPC
Diabetes non-insulin dependent
1.5
7.6
298
2162
H02AB07
ATC
prednisone; oral
1.6
7.3
172
1102
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
7.2
401
3113
K80
ICPC
Cardiac arrhythmia NOS
2.0
7.2
92
483
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
7.1
228
1575
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
12.1
7.1
12
10
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
6.9
137
833
UJD02
NOMESCO Finland
Gastroscopy
2.2
6.9
69
328
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
6.8
81
411
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
6.8
205
1397
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.7
6.8
44
167
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
6.8
205
1399
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
16.8
6.7
10
6
M79.6
ICD-10 Finland
Pain in limb
1.4
6.7
393
3069
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
3.0
6.7
35
117
UKC02
NOMESCO Finland
Cystoscopy
1.5
6.6
210
1446
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
6.6
206
1415
L03
ICPC
Low back symptom/complaint
1.5
6.6
261
1886
C05AA08
ATC
fluocortolone; rectal, topical
1.6
6.6
168
1095
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
6.6
312
2343
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
6.6
105
598
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
6.5
83
433
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.6
6.5
156
1005
H02AB06
ATC
prednisolone; systemic
1.4
6.4
545
4529
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.9
6.4
88
473
R03BB04
ATC
tiotropium bromide; inhalant
1.7
6.4
132
813
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
6.3
186
1260
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
6.3
177
1183
WX702
NOMESCO Finland
Supraglottic ventilation device
2.2
6.3
60
280
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.6
6.3
43
170
S17
ICPC
Abrasion/scratch/blister
3.2
6.3
31
100
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
6.3
154
997
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
6.2
102
588
N01
ICPC
Headache
1.9
6.2
83
445
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
6.2
94
525
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
6.2
133
831
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.5
6.2
47
196
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
6.1
88
484
I84.5
ICD-10 Finland
External hemorrhoids without complication
2.6
6.1
40
154
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
12.6
6.1
10
8
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.2
6.0
55
252

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022145) Colonoscopy Study observation
533
1323
5.87
214.42
1.5
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
357
1435
2.99
63.46
4.7
4.1
ug/l
10.1
22.3
1.07
281
1189
(40768804) Tissue Pathology biopsy report
719
4675
2.10
40.11
2.7
2.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
802
5469
2.08
38.90
6.0
6.1
%
2.8
2.9
0.32
746
5081
(3019069) Monocytes/100 leukocytes in Blood
802
5490
2.07
38.24
6.2
6.3
%
9.0
8.9
0.58
756
5122
(3022096) Basophils/100 leukocytes in Blood
782
5320
2.06
37.74
6.0
6.0
%
0.7
0.7
0.10
729
4951
(3018010) Neutrophils/100 leukocytes in Blood
797
5489
2.04
36.82
5.9
6.0
%
58.4
58.0
0.37
741
5117
(3002030) Lymphocytes/100 leukocytes in Blood
804
5583
2.02
35.96
6.2
6.2
%
26.5
26.7
0.20
748
5177
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
183
693
2.89
34.83
2.8
2.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
635
4092
2.00
34.73
5.5
5.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
337
1713
2.27
34.49
1.4
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1153
9345
2.29
31.63
9.4
7.9
u/l
79.8
79.7
0.04
1111
8757
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
577
3697
1.95
31.16
3.4
3.3
u/l
30.2
35.1
2.38
545
3501
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
523
3249
1.97
30.86
2.7
2.2
mg/l
3.4
3.1
1.11
453
2741
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
880
6535
1.92
29.83
7.1
6.4
umol/l
11.1
11.9
1.57
836
6189
(3013115) Eosinophils [#/volume] in Blood
822
6021
1.88
28.49
6.1
6.0
e9/l
0.2
0.2
0.21
714
5238
(3006315) Basophils [#/volume] in Blood
802
5835
1.87
28.33
6.0
5.8
e9/l
0.0
0.0
0.77
692
4997
(3001604) Monocytes [#/volume] in Blood
797
5814
1.85
27.63
6.1
5.8
e9/l
0.6
0.6
4.20
692
4966
(3019198) Lymphocytes [#/volume] in Blood
807
5927
1.85
27.19
6.1
5.8
e9/l
1.9
1.9
0.15
696
5169
(3013707) Erythrocyte sedimentation rate by Westergren method
1082
8768
2.01
26.47
5.0
4.2
mm/h
14.3
13.7
0.57
1019
8041
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
849
6364
1.84
26.46
7.2
7.1
mmol/l
1.2
1.2
0.61
734
5351
(3001122) Ferritin [Mass/volume] in Serum or Plasma
679
4768
1.82
26.13
3.4
2.7
ug/l
126.9
151.8
1.75
638
4318
(3004789) Transferrin [Mass/volume] in Serum or Plasma
335
1870
2.04
26.09
2.6
2.5
g/l
2.4
2.3
1.75
315
1734
(3024561) Albumin [Mass/volume] in Serum or Plasma
761
5571
1.80
25.10
5.7
4.9
g/l
35.0
34.9
0.12
712
5178
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
738
5359
1.79
24.97
2.3
2.1
pmol/l
95.4
94.2
0.26
387
2780
(3013650) Neutrophils [#/volume] in Blood by Automated count
885
6811
1.80
24.29
9.4
9.2
e9/l
4.3
4.2
0.32
761
5943
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
315
1773
2.00
23.72
2.7
2.6
%
20.3
22.5
1.73
273
1510
(3044640) Blood type and Crossmatch panel - Blood
573
3907
1.79
23.63
2.6
2.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
345
2020
1.94
23.09
2.6
2.5
umol/l
11.9
12.6
0.74
326
1861
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
256
1357
2.08
22.65
2.5
2.7
umol/l
7.2
9.0
1.27
216
1199
(3048689) Calprotectin [Mass/mass] in Stool
229
1166
2.15
22.50
2.0
2.2
ug/g
131.1
144.2
0.14
187
920
(3032080) INR in Blood by Coagulation assay
736
5446
1.74
22.38
10.1
10.7
inr
1.3
1.3
0.17
185
1524
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
565
3895
1.75
22.02
3.0
2.5
u/l
57.8
56.8
0.15
534
3576
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
775
5848
1.72
21.68
6.7
6.2
mmol/l
1.2
1.2
0.98
709
5264
(3033658) Prothrombin time (PT) actual/Normal
473
3109
1.78
21.67
5.0
4.0
%
86.9
86.9
0.01
464
3040
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
904
7127
1.75
21.51
3.9
3.2
u/l
55.3
55.2
0.01
853
6540
(3037467) Urinalysis macro (dipstick) panel - Urine
1007
8193
1.80
21.43
5.0
4.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
917
7300
1.73
20.63
5.8
5.0
mmol/l
6.9
6.9
0.04
879
6891
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1285
11432
2.41
20.05
22.7
16.4
mg/l
25.1
26.0
0.40
1121
9244
(3031040) Bacteria [#/volume] in Urine by Automated count
958
7956
1.64
16.04
5.4
4.8
e6/l
177.3
2256.9
1.97
12
130
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
435
3000
1.65
15.70
2.5
2.4
—
—
—
0
0
(3026782) Osmolality of Urine
382
2559
1.68
15.38
3.0
2.8
mosm/kgh2o
519.5
548.8
1.94
311
2175
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
721
5641
1.57
15.16
4.3
4.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
317
2036
1.72
14.86
3.4
3.1
e6/l
1.9
2.2
0.21
188
1163
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
372
2516
1.65
14.27
4.7
4.0
ng/l
502.7
362.9
0.26
306
2097
(3002582) Erythrocytes [#/volume] in Urine
522
3849
1.57
13.89
3.9
3.4
e6/l
39.5
84.3
1.59
409
3032
(3018095) Leukocytes [#/volume] in Urine
582
4399
1.55
13.86
4.4
3.8
e6/l
59.4
107.1
1.18
421
3247
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1177
10455
1.76
13.82
5.5
4.8
mu/l
1.9
2.1
0.81
1094
9411
(3021960) Folate [Moles/volume] in Serum or Plasma
448
3192
1.59
13.81
1.6
1.6
nmol/l
20.1
20.6
0.29
378
2678
(3027945) Reticulocytes/100 erythrocytes in Blood
258
1594
1.76
13.79
3.0
2.6
%
1.8
1.8
0.07
226
1417
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
111
517
2.25
13.42
3.4
3.3
u/ml
6187.4
7807.1
0.08
90
444
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
196
1126
1.86
13.31
2.8
2.3
u/l
32.6
36.8
0.73
169
961
(3009542) Hematocrit [Volume Fraction] of Blood
1133
10011
1.67
12.94
24.6
17.7
%
39.1
39.2
0.19
763
6490
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
552
4171
1.53
12.91
3.4
3.1
ng/l
2130.0
1513.9
1.14
484
3600
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1004
8623
1.57
12.84
4.2
3.9
pmol/l
15.0
15.0
0.16
920
7721
(3015377) Calcium [Moles/volume] in Serum or Plasma
565
4319
1.51
12.37
4.3
3.5
mmol/l
2.4
2.4
1.10
487
3732
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
149
802
1.96
12.30
3.5
3.8
mmol/l
1.4
2.0
1.40
111
610
(3019550) Sodium [Moles/volume] in Serum or Plasma
1306
12091
2.10
12.06
26.3
19.4
mmol/l
139.7
139.6
0.13
1283
11784
(3020630) Protein [Mass/volume] in Serum or Plasma
195
1152
1.80
12.05
2.7
3.0
g/l
66.5
66.2
0.18
172
1045
(3009343) pH of Capillary blood
153
838
1.93
11.99
3.7
3.9
ph
7.4
7.4
0.14
13
112
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
321
2174
1.62
11.97
3.3
2.8
e6/l
1.0
1.2
0.30
191
1298
(40758558) Short blood count panel - Blood
412
2958
1.56
11.97
7.6
6.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
128
661
2.03
11.87
1.5
1.8
g/l
1.7
1.6
0.59
109
572
(3022313) Gas panel - Capillary blood
121
614
2.06
11.77
3.8
3.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1307
12120
2.08
11.75
26.5
19.5
mmol/l
4.0
4.0
1.78
1285
11802
(3018418) pH of Serum or Plasma
507
3820
1.51
11.74
4.9
4.2
ph
7.4
7.4
0.01
82
732
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1206
10915
1.73
11.63
21.5
15.4
ml/min/173m2
75.6
75.5
0.03
1054
9065
(3019309) Folate [Moles/volume] in Red Blood Cells
376
2661
1.56
11.58
1.9
1.8
nmol/l
998.5
1191.7
4.02
290
1981
(3012095) Magnesium [Moles/volume] in Serum or Plasma
310
2101
1.61
11.48
3.9
3.3
mmol/l
0.8
0.8
1.15
290
1961
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
359
2520
1.57
11.45
1.8
1.7
mg/l
1.3
1.3
0.04
290
1975
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
153
851
1.90
11.44
3.7
3.9
kpa
5.1
5.2
0.40
139
797
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1310
12176
2.08
11.41
14.1
11.3
u/l
25.3
25.6
0.29
1277
11698
(3007164) IgA [Mass/volume] in Serum or Plasma
300
2021
1.62
11.38
1.5
1.5
g/l
2.6
2.6
0.11
166
1197
(3030467) Casts [#/volume] in Urine by Automated count
472
3535
1.50
11.11
3.8
3.2
e6/l
0.4
0.5
0.47
364
2738
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
104
512
2.11
10.96
3.5
4.2
mmol/l
24.5
25.1
1.24
91
478
(3037522) Nuclear Ab [Titer] in Serum
225
1421
1.69
10.95
1.4
1.3
titre
750.0
517.4
0.61
44
320
(3004588) Protein electrophoresis panel - Serum or Plasma
167
972
1.81
10.80
2.2
2.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
455
3400
1.50
10.76
3.8
3.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
624
4965
1.46
10.73
4.6
4.0
ng/l
55.8
51.1
0.13
471
3740
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1241
11376
1.76
10.73
5.8
5.0
mmol/l
6.2
6.1
1.53
1153
10212
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
202
1246
1.73
10.70
2.5
2.1
g/l
0.2
0.2
1.02
190
1161
(3000492) Spirometry study
172
1022
1.78
10.38
1.6
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
128
705
1.90
9.85
7.1
9.9
mmol/l
24.3
24.5
0.30
123
660
(3013512) EKG study
500
3862
1.46
9.80
4.9
4.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
234
1541
1.62
9.61
3.0
4.2
u/l
220.5
251.0
4.21
219
1453
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
104
539
2.00
9.56
2.0
2.8
g/l
3.9
3.8
0.28
75
392
(3022217) INR in Platelet poor plasma by Coagulation assay
268
1827
1.58
9.52
27.4
27.4
inr
1.5
1.4
0.55
40
238
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
104
540
2.00
9.51
2.0
2.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
104
540
2.00
9.51
2.0
2.8
g/l
7.3
7.4
0.20
75
406
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
503
3911
1.44
9.43
2.2
2.2
u/l
195.4
227.1
0.39
468
3670
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
159
950
1.76
9.40
1.6
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
480
3703
1.45
9.37
4.9
4.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
81
385
2.17
9.36
4.0
3.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
703
5820
1.41
9.24
2.8
2.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
313
2224
1.52
9.20
1.3
1.2
u/ml
3.2
1.6
0.49
63
575
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
601
4847
1.42
9.13
2.3
2.2
nmol/l
77.4
78.7
0.56
540
4244
(3003458) Phosphate [Moles/volume] in Serum or Plasma
258
1762
1.57
9.06
6.4
5.6
mmol/l
1.0
1.0
0.05
245
1623
(3002256) Pathology report gross observation
230
1532
1.60
8.98
1.2
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
503
2.00
8.91
2.1
2.8
g/l
2.9
3.2
1.75
77
398
(3000850) Epithelial cells [#/volume] in Urine
369
2733
1.47
8.81
2.7
2.6
e6/l
4.6
5.4
0.65
315
2402
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
97
507
1.98
8.72
1.9
2.8
g/l
10.8
10.5
0.27
83
431
(4035726)
179
1129
1.67
8.68
1.4
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
525
4180
1.41
8.39
4.2
4.0
mg/mmol
11.1
9.2
0.37
349
2639
(36660697) Celiac disease serology panel - Serum
133
781
1.78
8.34
1.2
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
187
1206
1.63
8.30
7.7
7.2
mmol/l
10.5
10.6
0.12
176
1146
(3021589) Normoblasts [#/volume] in Blood
625
5140
1.39
8.19
11.7
10.4
e9/l
0.0
0.0
0.24
509
4204
(3024869) Neuronal Ab [Presence] in Serum
14
23
6.14
8.19
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1261
11777
1.67
8.05
20.4
15.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
498
3952
1.40
8.03
3.4
3.3
mg/l
698.7
286.1
0.80
324
2531
(3026493) Urate [Moles/volume] in Serum or Plasma
424
3276
1.42
7.95
2.9
2.9
umol/l
4057.9
6809.6
0.73
357
2794
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
262
1845
1.52
7.93
1.3
1.2
iu/ml
38.7
35.3
0.13
75
593
(3037121) Protein [Mass/volume] in Urine
86
451
1.97
7.68
3.3
3.1
g/l
0.2
0.3
0.15
37
178
(3019225) pH of Specimen
198
1319
1.58
7.68
3.8
4.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
92
495
1.92
7.62
2.3
2.7
u/ml
0.4
0.4
0.09
53
280
(3010813) Leukocytes [#/volume] in Blood
1321
12529
1.87
7.58
33.5
24.1
e9/l
7.0
6.8
2.37
1291
12135
(3007461) Platelets [#/volume] in Blood
1320
12523
1.86
7.47
33.5
24.1
e9/l
245.9
243.8
0.51
1292
12171
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
88
470
1.93
7.46
2.0
3.0
g/l
0.8
1.4
0.74
73
404
(3024731) MCV [Entitic volume]
1320
12524
1.85
7.46
33.4
24.0
fl
91.4
91.6
0.64
1299
12309
(3003396) Base excess in Arterial blood by calculation
228
1578
1.53
7.45
6.6
7.5
mmol/l
0.8
1.2
0.84
188
1237
(3026361) Erythrocytes [#/volume] in Blood
1320
12526
1.85
7.42
33.5
24.1
e12/l
4.4
4.4
1.87
1292
12135
(3000963) Hemoglobin [Mass/volume] in Blood
1320
12528
1.85
7.39
33.7
24.2
g/l
132.0
134.0
4.61
1299
12310
(3009508) Creatinine [Moles/volume] in Urine
502
4032
1.38
7.39
3.5
3.2
mmol/l
7.4
7.3
0.20
416
3347
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
227
1576
1.52
7.31
6.6
7.5
kpa
5.0
5.1
0.80
221
1506
(3035941) MCH [Entitic mass]
1319
12524
1.83
7.25
33.3
24.0
pg
30.3
30.4
1.74
1300
12308
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1183
10945
1.50
7.21
7.6
6.4
mmol/mol
40.8
40.7
0.12
1099
10022
(3027801) Oxygen [Partial pressure] in Arterial blood
226
1577
1.52
7.10
6.6
7.4
kpa
12.0
11.8
0.23
218
1509
(3026008) Bacteria identified in Urine by Culture
486
3912
1.37
6.96
3.4
3.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
81
432
1.93
6.91
2.0
2.7
g/l
38.4
37.2
1.03
72
372
(3000570) Elastase.pancreatic [Mass/mass] in Stool
70
356
2.02
6.84
1.3
1.5
ug/g
321.3
270.1
1.19
41
220
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
73
382
1.96
6.59
1.5
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
166
1101
1.58
6.54
7.8
8.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
73
386
1.94
6.40
2.1
2.8
g/l
0.0
0.0
0.00
64
355
(3023520) Reticulocytes [#/volume] in Blood
177
1198
1.55
6.38
2.7
2.7
e9/l
72.0
69.3
0.46
132
939
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
52
243
2.18
6.35
1.1
1.2
—
70.0
—
0
6
(3013139) Helicobacter pylori Ag [Presence] in Stool
119
736
1.67
6.22
1.2
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
253
1854
1.44
6.17
1.9
2.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
171
1157
1.54
6.17
6.5
7.1
mmol/l
1.3
1.4
0.63
158
1115
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
118
730
1.67
6.16
7.3
10.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1204
11262
1.47
6.12
5.2
4.7
mmol/l
1.4
1.5
1.37
1115
10179
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1237
11634
1.52
6.12
5.9
5.3
mmol/l
2.6
2.6
0.65
1156
10541
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
75
407
1.89
6.10
2.1
2.8
g/l
0.0
0.0
1.19
66
374
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
177
1215
1.52
5.98
2.9
3.0
ng/l
219.1
221.7
0.03
164
1119
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
133
855
1.61
5.98
1.8
1.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
71
382
1.90
5.94
2.1
2.8
g/l
0.0
0.0
0.00
64
354
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
155
1035
1.56
5.93
3.9
3.7
ng/l
93.2
94.3
0.05
131
889
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1211
11357
1.47
5.91
5.2
4.7
mmol/l
4.5
4.5
0.47
1116
10351
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
63
327
1.97
5.85
1.2
1.3
—
25.0
—
0
5
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
223
1612
1.46
5.83
5.1
4.7
%
32.3
32.7
0.27
171
1055
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
402
3227
1.34
5.64
1.7
1.7
mmol/l
1.4
1.4
0.34
345
2663
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
74
418
1.81
5.34
1.5
1.5
—
165.6
—
0
18
(4010399)
135
902
1.55
5.16
1.5
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
318
2496
1.35
5.11
4.2
3.1
mmol/l
2.5
2.5
0.77
276
2206
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
286
2208
1.37
5.10
2.1
1.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
115
746
1.59
5.00
2.7
2.5
au/ml
28.7
17.6
—
5
27
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
160
1121
1.48
4.90
2.2
1.8
%
1.6
1.6
0.51
142
938
(3007853) Bacteria identified in Skin by Aerobe culture
195
1424
1.43
4.81
1.9
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1160
10897
1.37
4.69
4.6
4.2
mmol/l
1.3
1.3
0.89
1058
9766
(3021387) Prolactin [Units/volume] in Serum or Plasma
39
186
2.13
4.60
1.8
1.6
mu/l
211.7
275.6
1.98
34
169
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
96
611
1.61
4.54
5.0
3.8
mmol/l
24.6
24.1
0.78
88
549
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
54
292
1.88
4.52
4.2
3.3
u/ml
151.1
1317.6
0.74
47
274
(3000330) Specific gravity of Urine by Test strip
103
670
1.58
4.45
3.6
3.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
110
1613
0.66
4.39
9.2
7.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
133
2.28
4.24
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
930
8533
1.26
4.14
4.6
4.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
997
9225
1.28
4.13
29.7
20.1
%
14.1
13.9
3.07
986
9013
(3000494) Fungus identified in Specimen by Culture
191
1442
1.38
3.89
1.4
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
108
739
1.50
3.75
7.2
7.9
mmol/l
25.2
24.9
0.41
108
734
(3024928) Oxygen saturation in Venous blood
52
296
1.79
3.75
3.1
2.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
226
1762
1.34
3.74
1.3
1.2
u/ml
28.2
13.5
1.13
64
637
(3051611) Lipemic interference index of Serum or Plasma
30
141
2.15
3.72
3.1
3.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
15
50
3.02
3.69
3.7
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
75
475
1.61
3.67
2.6
2.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
79
510
1.58
3.58
1.6
2.0
u/l
38.3
39.1
0.11
72
452
(3002032) Base excess in Venous blood by calculation
164
1231
1.38
3.47
4.8
3.6
mmol/l
1.7
2.1
0.63
148
978
(3024980) IgG subclass 4 [Mass/volume] in Serum
32
159
2.04
3.46
1.3
1.7
g/l
0.8
0.9
0.11
23
126
(3036481) Cortisol [Moles/volume] in Serum or Plasma
144
1059
1.40
3.44
2.1
2.1
nmol/l
392.8
373.2
0.59
130
967
(3003181) Sodium [Moles/volume] in Urine
44
245
1.82
3.43
1.6
1.3
mmol/l
56.6
59.0
0.17
33
202
(3025941) Bacteria identified in Stool by Culture
87
583
1.52
3.36
1.3
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
199
1547
1.33
3.36
1.9
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
33
168
1.99
3.35
1.2
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
21
90
2.35
3.25
1.2
1.3
g/l
7.2
7.5
0.08
16
65
(3024139) IgG subclass 3 [Mass/volume] in Serum
21
90
2.35
3.25
1.2
1.3
g/l
0.3
0.4
0.36
16
65
(3006184) Hemoglobin [Mass/volume] in Capillary blood
48
280
1.74
3.22
2.1
2.3
g/l
123.6
127.9
0.51
29
213
(3017732) Neutrophils [#/volume] in Blood
111
789
1.44
3.21
3.6
3.1
e9/l
4.3
4.1
0.50
82
583
(3023420) DNA double strand Ab [Units/volume] in Serum
23
104
2.23
3.16
1.3
1.3
—
35.8
—
0
6
(3017446) Testosterone [Moles/volume] in Serum or Plasma
116
835
1.42
3.14
2.9
2.2
nmol/l
12.8
12.7
0.02
97
723
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
534
4714
1.21
3.06
5.9
5.3
ug/l
2.0
3.0
3.02
476
4183
(3037756) Immunofixation for Serum or Plasma
54
331
1.66
3.05
1.3
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
102
722
1.44
3.03
1.9
1.9
g/l
1.5
1.5
0.04
97
664
(3005719) IgG [Mass/volume] in Serum or Plasma
123
901
1.40
3.03
2.7
2.9
g/l
10.9
10.8
0.02
117
826
(3021447) Carbon dioxide [Partial pressure] in Venous blood
162
1242
1.34
3.01
4.7
3.6
kpa
5.8
5.8
0.48
157
1204
(1761482) Bacteria [#/volume] in Urine by Culture
57
356
1.63
3.00
4.0
5.0
—
—
—
0
0
(4062490)
21
94
2.25
2.97
1.2
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
44
258
1.73
2.93
1.3
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
25
122
2.07
2.88
1.2
1.2
u/l
53.2
50.7
0.12
15
87
(4146454)
30
157
1.93
2.86
2.5
2.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
34
186
1.85
2.84
1.1
1.1
—
—
—
0
0
(3036489) Thrombin time
63
410
1.56
2.81
2.1
2.0
s
21.2
21.7
0.51
57
369
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
79
542
1.48
2.77
2.2
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
30
160
1.89
2.72
1.5
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
19
85
2.25
2.71
3.5
3.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
34
190
1.81
2.68
1.5
1.2
u/l
11.6
10.3
0.14
23
149
(3017143) Hepatitis C virus Ab [Presence] in Serum
131
992
1.35
2.66
1.7
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
77
531
1.48
2.65
2.0
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
632
5726
1.19
2.62
3.9
3.9
estimate
0.0
0.0
0.00
100
1089
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
15
61
2.47
2.62
3.0
2.1
nmol/l
15.5
17.2
0.41
15
55
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
48
298
1.63
2.62
1.4
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
86
610
1.44
2.57
1.1
1.2
iu/ml
112.9
144.2
0.30
30
237
(3014051) Protein [Presence] in Urine by Test strip
47
292
1.63
2.56
2.4
2.2
—
—
—
0
0
(4015189)
12
44
2.74
2.55
2.2
2.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
82
578
1.44
2.53
2.3
2.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
30
165
1.84
2.50
1.2
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
82
580
1.44
2.49
3.7
5.3
%
1.7
1.6
0.55
82
546
(3034860) Kappa light chains.free [Mass/volume] in Serum
70
480
1.48
2.49
3.1
4.0
mg/l
60.6
66.6
0.14
58
390
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
70
480
1.48
2.49
3.1
4.0
mg/l
41.2
82.5
0.83
58
392
(3005011) Chlamydia sp Ab [Titer] in Serum
7
16
4.39
2.47
1.7
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
123
934
1.35
2.47
4.3
4.8
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
21
103
2.05
2.42
1.2
1.2
nmol/l
379.9
362.9
0.09
13
86
(3003327) Ova and parasites identified in Stool by Light microscopy
48
305
1.59
2.41
1.9
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
47
300
1.59
2.32
1.2
1.1
titre
101.7
95.4
—
6
24
(3005570) Glucose [Moles/volume] in Urine
25
133
1.90
2.32
2.0
2.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
35
207
1.71
2.31
1.3
1.4
g/l
33.6
32.0
0.23
27
188
(3032773) Endomysium IgG Ab [Titer] in Serum
17
78
2.19
2.31
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
338
2924
1.21
2.30
1.3
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
51
333
1.55
2.29
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
70
489
1.45
2.29
1.9
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
53
2.47
2.28
1.2
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
134
1044
1.31
2.27
1.7
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
971
9185
1.18
2.26
30.5
21.6
g/l
330.9
331.7
2.23
963
9123
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
21
106
2.00
2.26
1.1
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
18
3.90
2.25
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
51
335
1.54
2.24
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
66
458
1.46
2.24
1.3
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
319
2753
1.21
2.22
3.6
3.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
65
451
1.46
2.21
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
26
143
1.83
2.19
1.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
151
1203
1.29
2.18
1.7
1.5
—
—
—
0
0
(1002224) Polysomnography panel
52
346
1.52
2.17
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
60
412
1.48
2.16
1.2
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
14
4.30
2.15
1.7
1.3
umol/l
79.5
34.9
—
6
14
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
189
1550
1.25
2.15
2.0
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
50
331
1.53
2.14
1.2
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
79
573
1.40
2.13
3.5
5.3
%
0.9
0.9
0.62
79
540
(3035880) pH of Pleural fluid
18
88
2.06
2.11
1.2
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
68
2.22
2.11
1.6
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
68
2.22
2.11
3.1
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
162
1313
1.26
2.04
1.4
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
22
118
1.88
2.02
1.5
2.1
—
1.1
—
0
5
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
81
597
1.38
2.00
3.0
3.1
pmol/l
4.4
4.4
0.06
70
514
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
85
632
1.37
1.99
3.5
2.4
%
0.7
0.7
0.24
85
608
(3022621) pH of Urine by Test strip
104
802
1.32
1.93
3.5
3.0
—
—
—
0
0
(3000012) Reticulocyte production index
15
71
2.12
1.92
1.2
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
629
5800
1.15
1.90
4.0
3.9
estimate
0.0
0.0
0.80
100
1062
(3023183) Ammonium ion [Moles/volume] in Plasma
44
292
1.52
1.89
3.9
2.7
umol/l
32.6
33.2
0.08
36
244
(3021601) Nitrite [Presence] in Urine by Test strip
622
5739
1.15
1.85
5.5
5.2
estimate
0.0
0.0
0.00
103
1097
(44816559) Phosphatidylethanol [Mass/volume] in Blood
31
190
1.65
1.85
1.2
1.2
—
—
—
0
0
(4034850)
23
390
0.58
1.83
15.8
11.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
78
581
1.36
1.83
2.0
1.9
ug/l
1.6
2.7
0.46
70
511
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
27
160
1.70
1.82
1.1
1.2
—
0.5
—
0
13
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
12
4.18
1.82
1.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
12
4.18
1.82
1.0
1.6
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
12
4.18
1.82
1.0
1.2
%
108.4
94.2
—
5
12
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
73
2.07
1.81
1.1
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
28
169
1.67
1.78
1.2
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
28
169
1.67
1.78
1.3
1.5
—
—
—
0
0
(4198724)
6
18
3.34
1.74
2.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
28
170
1.66
1.74
1.2
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
28
170
1.66
1.74
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
28
170
1.66
1.74
1.3
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
51
356
1.45
1.74
1.4
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
29
178
1.64
1.73
2.7
2.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
71
526
1.37
1.73
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
125
1.77
1.72
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
26
156
1.68
1.69
1.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
23
134
1.73
1.66
4.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
134
1.73
1.66
4.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
37
244
1.53
1.66
1.3
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
43
293
1.48
1.66
4.1
3.4
mmol/l
7.1
7.7
1.57
43
285
(3024354) Oxygen [Partial pressure] in Venous blood
128
1037
1.26
1.65
4.0
2.9
kpa
4.7
4.5
0.40
122
1001
(3029937) Albumin [Presence] in Urine by Test strip
281
3191
0.85
1.65
4.8
4.2
estimate
0.0
0.0
0.37
101
1046
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
142
1.70
1.65
1.9
1.4
—
—
—
0
0
(4281824)
22
127
1.74
1.64
1.2
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
43
294
1.48
1.64
1.3
1.2
—
16.2
—
0
16
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
49
2.25
1.63
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
23
136
1.70
1.59
4.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
23
136
1.70
1.59
4.3
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
61
448
1.38
1.59
1.3
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
26
2.70
1.58
1.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
281
1.47
1.56
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
281
1.47
1.56
1.6
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
273
1.48
1.55
1.4
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
24
145
1.67
1.54
1.2
1.4
mmol/l
6.9
6.6
0.16
18
137
(3015235) Bicarbonate [Moles/volume] in Capillary blood
50
357
1.42
1.54
4.3
3.4
mmol/l
24.6
24.9
0.17
43
310
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
169
1.61
1.52
1.2
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
138
1.68
1.52
1.2
1.2
nmol/l
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
27
2.60
1.51
1.9
1.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
15
79
1.91
1.49
1.1
1.4
—
63.6
—
0
11
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
307
2731
1.16
1.48
3.7
3.2
ug/l
0.9
0.8
0.58
236
1901
(3016879) Cocaine [Presence] in Urine
21
125
1.69
1.44
4.6
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
49
354
1.40
1.43
2.5
4.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
133
1.66
1.43
1.1
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
141
1.64
1.42
2.0
2.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
230
1.49
1.40
3.7
3.2
%
59.2
59.2
0.00
34
230
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
55
408
1.36
1.38
1.3
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
166
1.58
1.38
1.3
1.3
e6/l
84594.5
105854.4
0.13
11
102
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
174
1.56
1.37
1.8
2.6
mg/l
32.0
26.0
—
5
43
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
40
281
1.44
1.37
1.3
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
224
2551
0.86
1.37
4.8
4.4
kg/l
1.0
1.0
0.60
38
388
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
5
17
2.95
1.36
1.0
1.2
u/l
25.2
27.7
—
5
11
(3000034) Microalbumin [Mass/volume] in Urine
19
112
1.71
1.35
3.5
3.4
mg/l
22.9
33.1
0.23
12
88
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
68
1.92
1.33
1.3
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
40
283
1.43
1.32
1.3
1.2
u/ml
3.0
6.8
—
5
43
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
43
2.10
1.30
3.0
2.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
43
310
1.40
1.29
4.1
3.3
mmol/l
1.5
1.6
0.80
43
301
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
210
1.49
1.28
1.3
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
20
122
1.65
1.27
1.1
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
47
346
1.37
1.26
1.5
1.6
iu/ml
48.2
18.6
0.24
15
65
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
36
2.23
1.24
1.4
1.1
iu/ml
204.8
242.2
—
8
36
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
215
0.55
1.23
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
22
139
1.59
1.23
4.1
3.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
24
155
1.56
1.23
1.5
2.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
26
385
0.67
1.23
1.5
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
116
1.65
1.21
1.5
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
115
959
1.22
1.20
3.7
4.3
%
0.0
0.4
0.63
23
260
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
64
1.88
1.18
3.7
3.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
57
1.94
1.17
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
102
1.67
1.16
4.9
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
160
1381
1.18
1.16
4.2
3.5
—
—
—
0
0
(4094501)
46
343
1.35
1.15
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
24
158
1.53
1.15
1.3
1.6
%
62.2
63.7
0.06
13
107
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
33
233
1.43
1.13
1.8
1.7
iu/l
3.8
5.3
—
9
67
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
143
1.55
1.11
1.3
1.2
u/ml
2.3
4.8
1.01
12
71
(3004616) Nuclear Ab [Presence] in Serum
22
143
1.55
1.11
1.5
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
66
1.83
1.09
7.0
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
32
2.19
1.08
4.1
3.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
89
1.69
1.07
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
330
3600
0.89
1.07
3.8
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
312
2842
1.13
1.07
1.9
1.7
pmol/l
34252404.7
19180901.5
0.18
254
2294
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
141
1214
1.18
1.06
2.4
2.5
ug/l
6.2
7.2
0.50
115
1073
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
21
137
1.54
1.06
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
25
170
1.48
1.05
1.1
1.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
9
46
1.96
1.03
36.3
29.2
ug/l
99.9
124.8
—
9
39
(4024509)
19
122
1.56
1.02
1.5
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
47
1.92
1.02
1.7
2.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
43
325
1.33
1.01
1.9
2.1
mg/l
10.6
12.0
0.69
37
302
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
51
650
0.78
1.00
2.2
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
35
2.00
1.00
1.1
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
26
181
1.44
0.98
1.2
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
26
181
1.44
0.98
1.2
1.3
miu/ml
294.8
182.0
—
9
78
(3006653) Thiamine [Moles/volume] in Blood
11
61
1.81
0.98
1.0
1.2
nmol/l
151.4
135.8
0.41
11
61
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
29
0.00
0.97
0.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
36
1.95
0.97
2.1
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
23
157
1.47
0.96
1.3
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
199
1.42
0.96
1.7
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
126
1087
1.17
0.95
5.1
3.8
mmol/l
1.2
1.2
0.26
111
940
(3001686) Cold agglutinin [Titer] in Serum or Plasma
6
27
2.23
0.93
1.0
1.3
—
183.0
—
0
6
(3025130) Human papilloma virus identified in Specimen
12
70
1.72
0.92
1.2
1.7
—
—
—
0
0
(4306422)
20
134
1.50
0.92
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
78
647
1.22
0.90
1.3
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
30
219
1.38
0.90
3.9
3.0
e9/l
4.9
4.5
0.33
30
219
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
33
245
1.36
0.89
1.4
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
124
1075
1.17
0.89
3.7
4.2
%
0.7
0.9
0.40
27
329
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
144
1264
1.16
0.88
1.4
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
117
1011
1.17
0.87
3.8
4.2
%
0.1
0.1
0.05
24
300
(3042631) Mycobacterium sp identified in Specimen
28
203
1.39
0.87
3.0
2.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
26
187
1.40
0.85
1.4
1.4
e6/l
867.7
1749.6
2.62
15
137
(3019977) pH of Arterial blood
13
80
1.63
0.84
1.6
3.4
ph
7.5
7.4
—
6
27
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
31
1.94
0.84
5.3
2.9
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
31
1.94
0.84
1.7
2.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
45
1.78
0.84
1.5
2.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
197
1.38
0.82
1.3
1.3
iu/l
31.7
32.5
0.03
18
167
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
249
1.33
0.82
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
30
223
1.35
0.82
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
46
364
1.27
0.82
1.2
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
28
206
1.37
0.81
1.2
1.2
—
40.5
—
0
16
(3048879) Bone marrow aspiration report
8
47
1.71
0.80
1.4
2.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
58
1.73
0.79
1.4
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
58
1.73
0.79
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
58
1.73
0.79
1.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
48
1.67
0.78
1.0
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
48
1.67
0.78
2.1
2.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
98
1.54
0.78
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
25
338
0.73
0.78
2.2
1.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
74
1.63
0.78
1.3
1.5
u/l
5.8
8.2
—
5
37
(3045788) Cell count panel - Pleural fluid
21
148
1.43
0.78
1.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
96
1109
0.86
0.76
3.6
3.5
—
—
—
0
0
(3020891) Body temperature
43
537
0.79
0.76
7.4
4.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
41
324
1.27
0.75
1.6
1.5
g/l
0.2
0.2
0.87
36
305
(3021901) Oxygen saturation in Capillary blood
34
262
1.31
0.75
3.9
3.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
210
1.34
0.74
5.9
3.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
111
971
1.16
0.74
3.7
4.0
%
0.4
0.6
0.91
22
239
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
108
1.49
0.73
1.4
1.4
%
18.1
29.8
—
9
70
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
21
150
1.41
0.73
1.1
1.1
—
15.8
—
0
7
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
403
3795
1.09
0.72
4.7
4.5
%
22.0
21.6
0.22
209
1939
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
39
1.80
0.72
27.3
16.1
nmol/l
1158.7
1656.6
—
7
39
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
57
1.58
0.71
2.1
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
57
1.58
0.71
2.1
2.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
37
292
1.27
0.70
4.4
4.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
58
1.56
0.70
2.1
2.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
27
1.85
0.68
5.8
4.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
27
1.85
0.68
10.8
6.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
27
1.85
0.68
1.4
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
144
1.39
0.68
1.4
1.2
u/ml
1.7
3.9
—
6
48
(3035637) Corticotropin [Mass/volume] in Plasma
18
127
1.42
0.68
1.4
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
40
321
1.25
0.67
1.2
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
197
1.33
0.66
1.1
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
70
1.58
0.65
1.1
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
70
1.58
0.65
1.1
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
258
2395
1.09
0.65
4.7
4.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
242
1.29
0.64
1.5
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
39
314
1.25
0.64
4.2
7.2
mmol/l
105.7
105.3
0.25
39
284
(3039000) Anion gap in Blood
39
314
1.25
0.64
4.2
7.2
mmol/l
11.5
11.2
0.32
39
284
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
189
0.68
0.64
2.0
1.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
29
1.73
0.64
10.8
6.9
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
79
1.52
0.62
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
79
1.52
0.62
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
79
1.52
0.62
1.2
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
50
1.60
0.61
1.3
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
50
1.60
0.61
1.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
290
1.25
0.60
1.4
1.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
80
1.50
0.60
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
80
1.50
0.60
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
80
1.50
0.60
1.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
72
1.53
0.59
1.9
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
72
1.53
0.59
1.9
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
72
1.53
0.59
1.9
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
72
1.53
0.59
1.9
1.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
81
1.49
0.57
1.2
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
81
1.49
0.57
1.2
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
23
176
1.31
0.56
1.8
2.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
41
338
1.22
0.56
1.7
1.5
g/l
1.1
1.2
0.30
35
321
(21494814) CD8 cells/100 lymphocytes in Specimen
6
38
1.58
0.54
2.2
1.8
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
6
38
1.58
0.54
1.0
1.1
pmol/l
237.3
251.3
—
6
24
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
420
4399
0.94
0.54
4.5
4.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
60
1.50
0.54
1.0
1.1
—
—
—
0
0
(44813793)
9
60
1.50
0.54
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
62
1.45
0.53
1.4
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
91
1.43
0.53
1.5
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
91
1.43
0.53
6.5
1.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
87
772
1.14
0.52
1.7
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
24
188
1.28
0.51
1.3
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
9
65
1.39
0.50
1.9
2.9
ml
1715.6
1896.7
—
9
57
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
123
1117
1.11
0.50
1.5
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
41
1.47
0.50
1.0
1.0
—
—
—
0
0
(44806118)
10
144
0.69
0.49
2.1
1.6
—
—
—
0
0
(44790049)
10
144
0.69
0.49
2.1
1.6
—
—
—
0
0
(44790047)
10
144
0.69
0.49
2.1
1.6
—
—
—
0
0
(44790048)
10
144
0.69
0.49
2.1
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
45
1.56
0.49
1.4
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
46
1.52
0.48
1.0
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
40
336
1.20
0.48
3.1
3.2
nmol/l
0.8
0.8
0.12
30
263
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
47
1.49
0.47
1.3
2.3
—
44693.9
—
0
10
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
35
417
0.84
0.45
1.8
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
55
480
1.15
0.43
3.0
2.2
ug/l
222.0
482.3
1.40
55
453
(3024471) HLA-A [Type]
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
31
1.62
0.43
2.6
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
68
604
1.13
0.42
1.3
1.2
u/ml
141.6
188.3
0.65
63
551
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
5
34
1.47
0.40
1.0
1.2
mu/l
77.3
69.4
—
5
24
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
18
0.00
0.40
0.0
5.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
102
0.68
0.39
1.1
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
97
1.34
0.39
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
35
1.43
0.39
2.2
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
15
115
1.31
0.39
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
39
335
1.17
0.38
1.4
1.7
e6/l
8549.9
16736.8
1.33
28
252
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.36
1.3
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
70
1.29
0.36
1.4
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
11
81
1.36
0.36
1.5
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
90
982
0.91
0.35
3.5
2.9
ml/min/173m2
59.0
61.7
0.34
53
416
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
43
376
1.15
0.35
1.7
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
246
1.18
0.34
1.4
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
91
1.32
0.33
1.8
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
45
1.33
0.33
2.0
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
45
1.33
0.33
2.0
2.9
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
6
45
1.33
0.33
1.2
1.4
g/l
13.2
15.2
—
6
34
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
58
520
1.12
0.33
1.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
313
3007
1.05
0.33
3.8
3.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
74
1.35
0.32
2.1
1.5
g/l
1.1
1.0
—
10
74
(4268621)
13
101
1.29
0.31
2.5
2.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
110
1.28
0.31
1.4
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
34
296
1.15
0.30
1.1
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
84
1.31
0.30
1.2
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
110
0.73
0.29
1.3
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
13
103
1.26
0.28
2.2
1.8
u/field
2.0
2.4
—
6
42
(3020191) Ethanol [Moles/volume] in Serum or Plasma
10
76
1.32
0.28
1.4
1.4
promille
2.2
1.0
—
10
61
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
64
1.25
0.27
1.1
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
120
0.75
0.27
1.2
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
65
1.23
0.27
2.0
2.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
67
1.20
0.26
1.4
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
35
310
1.13
0.26
1.5
1.8
mg/l
1.7
4.4
0.87
24
237
(3028271) Lactate [Moles/volume] in Capillary blood
26
225
1.16
0.26
1.7
2.0
mmol/l
2.0
1.6
0.48
26
220
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
75
0.67
0.26
1.8
2.4
%
13.3
13.3
—
5
75
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
30
264
1.14
0.24
1.4
1.4
e6/l
202.9
666.7
0.56
24
215
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
30
264
1.14
0.24
1.3
1.3
e6/l
3.8
42.3
1.02
21
207
(21494434) Karyotype in Bone marrow
17
142
1.20
0.24
1.4
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
16
133
1.21
0.24
1.3
1.3
e6/l
28908.5
93201.4
—
10
93
(3026389) Candida sp identified in Specimen by Organism specific culture
12
147
0.81
0.23
1.3
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
35
313
1.12
0.23
1.4
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
38
1.32
0.23
1.0
1.1
miu/ml
1197.8
1599.2
—
5
38
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
124
0.81
0.21
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
44.6
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
6
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
5
43
1.16
0.21
9.4
6.3
%
46.2
74.2
—
5
34
(40767503) Oxygen content in Capillary blood by calculation
32
287
1.12
0.21
2.9
2.7
%
15.8
15.9
0.07
19
149
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
12.5
—
0
13
(3050794) Legionella sp Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
48
1.25
0.20
6.2
2.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
118
1.19
0.19
1.2
1.0
u/ml
7.0
2.1
—
5
42
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
7
60
1.17
0.17
2.3
5.8
—
82.1
—
0
13
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
60
1.17
0.17
1.0
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
13
110
1.18
0.17
1.2
1.2
nmol/l
1.3
1.4
0.05
13
94
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
67
0.75
0.17
1.0
1.4
nmol/l
0.7
1.1
—
5
50
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
68
1.18
0.16
1.1
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
68
1.18
0.16
1.1
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
72
1.11
0.16
5.4
14.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
73
1.10
0.15
1.8
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
81
1.11
0.15
2.4
2.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
192
0.88
0.14
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
86
0.81
0.14
1.6
2.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
56
593
0.94
0.14
1.2
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
96
0.83
0.13
1.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
104
1.16
0.12
1.8
1.7
%
12.0
10.8
0.45
12
104
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
191
1.10
0.11
1.5
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
106
1025
1.04
0.11
4.2
4.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
29
269
1.08
0.11
1.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
37
347
1.07
0.11
2.3
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
86
1.16
0.11
1.3
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
115
1.13
0.10
1.3
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
249
0.92
0.10
1.5
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
106
1.13
0.09
1.2
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
116
1.12
0.09
1.5
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
54
1.11
0.09
1.8
1.3
—
—
—
0
0
(4211845)
6
54
1.11
0.09
6.2
2.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
19
175
1.09
0.08
1.3
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
31
293
1.06
0.08
5.6
5.1
mmol/l
3.2
2.8
0.39
25
203
(40768441) Liver Pathology biopsy report
11
98
1.12
0.07
1.5
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
72
0.83
0.07
1.2
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
72
0.83
0.07
1.2
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
74
0.81
0.07
1.0
1.5
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
8
78
1.03
0.07
1.1
1.2
mg/l
47.6
38.3
—
8
69
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
80
0.87
0.07
2.4
2.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
84
0.83
0.07
2.4
2.6
—
—
—
0
0
(3017704) Immunofixation for Urine
9
87
1.03
0.07
1.0
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
254
0.94
0.06
1.8
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
129
1.09
0.05
1.9
2.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
35
336
1.04
0.05
2.3
2.4
ug/min
320.3
92.0
0.79
23
203
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
149
1.07
0.05
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
100
1.10
0.05
1.0
1.0
u/ml
0.9
4.4
—
6
41
(3039443) Prostate specific Ag panel - Serum or Plasma
23
219
1.05
0.04
1.7
1.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
12
129
0.93
0.03
1.1
1.2
mmol/l
7.0
7.6
—
6
93
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
220
1.05
0.03
1.7
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
159
0.94
0.03
6.7
4.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
108
0.93
0.03
1.4
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
108
0.93
0.03
2.0
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
319
0.97
0.02
1.8
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
178
0.95
0.02
1.8
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
24
232
1.04
0.02
2.0
1.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
117
0.94
0.01
1.3
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
263
1.03
0.01
4.8
3.7
mg/l
31.8
26.9
0.18
17
171
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
62
613
1.01
0.01
6.2
3.8
%
44.7
49.1
0.77
62
605
(3010421) pH of Blood
36
356
1.01
0.00
5.9
4.7
ph
7.4
7.4
0.82
31
289
(3003740) Influenza virus B Ag [Presence] in Specimen
11
109
1.01
0.00
1.2
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
121
0.99
0.00
1.9
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
121
0.99
0.00
1.9
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
121
0.99
0.00
1.9
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
131
0.99
0.00
1.8
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
18
181
0.99
0.00
1.6
1.2
u/ml
356.9
308.4
0.25
13
98
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
25
249
1.00
0.00
5.5
5.9
iu/ml
450.0
825.5
—
6
36
(3045142) Bone marrow Pathology biopsy report
16
157
1.02
0.00
1.4
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
20
197
1.02
0.00
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
305
1.02
0.00
1.8
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
145
0.97
0.00
1.9
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
23
225
1.02
0.00
1.3
1.5
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
397.5
—
0
8
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
140
1.00
0.00
1.8
1.8
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.5
—
0
6
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
59
0.85
0.00
5.6
6.3
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
89
1.01
0.00
1.2
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
74
0.95
0.00
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
110
1.00
0.00
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
91
0.99
0.00
2.4
2.3
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.9
—
0
5
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.8
—
18.8
—
0
6
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
52
0.96
0.00
2.4
1.6
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
76
0.92
0.00
1.1
1.1
mg/l
241.4
249.1
—
7
68
(3025549) Creatine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
75
0.93
0.00
1.1
2.9
—
—
—
0
0
(44806420)
5
50
1.00
0.00
2.6
2.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint CD2_BENIGN_RECTOSIGMOID_JUNC and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_RECTOSIGMOID_JUNC 1.169 [1.03, 1.32] 0.013
Birth year 0.997 [0.99, 1.01] 0.425

During the follow-up period (1.1.1998 — 31.12.2019), 680 out of 3167 females with CD2_BENIGN_RECTOSIGMOID_JUNC died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_RECTOSIGMOID_JUNC 1.224 [1.08, 1.39] 0.001
Birth year 0.986 [0.97, 1.0] 0.02

During the follow-up period (1.1.1998 — 31.12.2019), 919 out of 3357 males with CD2_BENIGN_RECTOSIGMOID_JUNC died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_RECTOSIGMOID_JUNC.

N-year risk Females Males
1 0.101% 0.256%
5 0.705% 1.504%
10 1.808% 3.471%
15 3.541% 6.366%
20 6.085% 10.725%

Relationships between endpoints

Index endpoint: CD2_BENIGN_RECTOSIGMOID_JUNC – Benign neoplasm: Rectosigmoid junction

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data